Health
HSA Alert: ‘Li Da’ and ‘Chapter Plus’ sold online found to contain banned substance, Sibutramine
Members of the public are alerted not to purchase or consume two slimming products ‘Li Da Weight Loss Capsule (‘Li Da’)’ and ‘Chapter Plus By BackSlim (‘Chapter Plus’)’ as they contain an undeclared and banned substance, sibutramine, which poses serious health risks.
In a press release on Friday (20 July), the Health Sciences Authority (HSA) stated that it had tested both products and found them to contain sibutramine.
HSA said that both products were found to be sold on various local online platforms and that its preliminary investigations showed that a number of people may have bought the products online.
According to the authority, Sibutramine has been withdrawn in Singapore since 2010 due to an increased risk of heart attacks and strokes.
In recent years, HSA noted that it has detected several slimming products adulterated with Sibutramine, which have caused serious adverse effects in Singapore consumers, including breathing difficulties, palpitations, mood swings, hallucinations and hearing of voices.
The product ‘Li Da’ is similar to two other illegal slimming products “Li Da DAIDAIHUA Weight Loss Capsule’ and ‘Lida (Plus)’, which were detected to be adulterated with Sibutramine by HSA and Australia’s Therapeutic Goods Administration in November 2014 and March 2018 respectively.
Both ‘Li Da’ and ‘Li Da DAIDAIHUA’ were falsely labelled to mislead consumers into thinking that they were diet supplements containing ‘100% herbal’ ingredients, with ‘no chemicals’ and carried claims that they ‘work fast’ with ‘no side effects’, HSA said.
Meanwhile, the authority stated that ‘Chapter Plus’ was falsely marketed as a ‘100% safe’ dietary supplement with ‘100% natural herbs’ and ‘no side effects’. A consumer complained of an increase in heart rate following the consumption of ‘Chapter Plus’ purchased online from a local company ‘OUR COCOMO Pte Ltd’. The company is currently assisting with HSA in its investigations.
HSA advised to:
- Stop taking ‘Li Da’ or ‘Chapter Plus’ immediately, and consult a doctor if you feel unwell or are concerned about your health.
- Be wary of health products that promise or deliver quick and miraculous weight loss, or carry exaggerated and extreme claims such as ‘100% safe’ and ‘no side effects’.
- Do not trust online product reviews, as these testimonials usually cannot be verified. If they seem too good to be true, they usually are.
- Exercise caution when purchasing health products online, especially from unfamiliar websites and if the products carry exaggerated claims. Anyone can sell health products on these e-commerce platforms. You cannot be certain where and how these products were made. They could potentially be counterfeits or adulterated with undeclared potent or banned ingredients which can seriously harm your health.
The authority also warned all sellers and suppliers to stop selling ‘Li Da’ and ‘Chapter Plus’ immediately, saying that these are illegal products which contain banned ingredients.
It stressed that anyone who supplies illegal health products is liable to prosecution and if convicted, may be imprisoned for up to 3 years and/or fined up to $100,000.
Members of the public who have any information on the sale and supply of these illegal products may contact HSA’s Enforcement Branch at Tel: 6866-3485 during office hours (Monday to Friday) or email: [email protected].
Health
Singapore to offer Mpox vaccine to high-risk healthcare workers and close contacts
Singapore will offer free mpox vaccines to high-risk healthcare workers and close contacts of confirmed cases, amid concerns over the deadlier clade 1 strain. The Ministry of Health stated mask-wearing is unnecessary for the public, as the virus primarily spreads through close contact.
Singapore has announced new measures to combat the spread of the deadlier mpox clade 1 strain, as concerns mount over its potential impact.
At a press conference on Wednesday, Health Minister Ong Ye Kung revealed that the mpox vaccine JYNNEOS will be offered to two key groups: healthcare workers at high risk of exposure and close contacts of confirmed cases.
The announcement comes as the World Health Organization (WHO) declared mpox a global public health emergency for the second time in two years due to the resurgence of clade 1 cases in Africa.
Minister Ong emphasized that while there is limited data on the virus, the government has sufficient information to implement precautionary measures. “We do not have full information on the characteristics of this virus, but we have good information on how it behaves,” he said. Ong added that Singapore’s response plan would remain flexible and adapt as the global understanding of the virus evolves.
Response Measures and Border Controls
As part of a whole-of-government approach, the Ministry of Health (MOH) has coordinated a comprehensive public health strategy to prevent the spread of mpox clade 1 in Singapore.
While no direct flights connect Singapore to countries experiencing mpox outbreaks, temperature and visual screening measures have been put in place at Changi and Seletar airports for travellers and crew arriving from affected regions. Screening at sea checkpoints has also been implemented for ships from mpox-affected areas.
Travellers are required to report any mpox-related symptoms (such as fever or rash) and provide travel history via the SG Arrival Card. Those displaying symptoms will be assessed by medical professionals at the borders and referred to hospitals if necessary.
Vaccination Strategy and Quarantine
The JYNNEOS vaccine, previously approved in Singapore for both smallpox and mpox, will be offered to two key groups. Healthcare workers at the National Centre for Infectious Diseases (NCID) and other high-risk facilities will be provided with pre-exposure prophylaxis, in addition to existing infection control protocols. Close contacts of confirmed mpox cases will receive a single vaccine dose within 14 days of exposure during their 21-day quarantine period. The MOH has assured that the current vaccine supply is sufficient to meet the needs of these priority groups.
MOH highlighted that a “significant” portion of the population—those born before 1981—may already have some immunity due to mandatory smallpox vaccinations administered in Singapore until that year.
Detection, Isolation, and Treatment
MOH has instructed all healthcare providers to be vigilant and promptly report any suspected mpox cases, especially those involving clade 1.
Suspected cases will be referred to designated hospitals for further assessment and testing, with paediatric cases directed to KK Women’s and Children’s Hospital and adult-child family groups to National University Hospital. Confirmed clade 1 cases will be isolated in healthcare facilities until they are no longer infectious to prevent further community spread.
Testing for mpox involves polymerase chain reaction (PCR) testing conducted at the National Public Health Laboratory. While there are no rapid point-of-care test kits available, cases are managed through supportive care. For severe cases, antivirals such as Tecovirimat may be used, aligning with treatment protocols in other countries.
Community Measures and Mask-Wearing
Based on current data, the virus spreads mainly through close physical contact, such as within households. Therefore, mask-wearing for the general public is not recommended unless there is significant evidence of respiratory transmission. MOH has stated that if respiratory spread becomes a concern, measures such as mask-wearing on public transport or in crowded indoor spaces may be considered.
In settings such as preschools and schools, existing infectious disease protocols—such as visual screenings for symptoms and hygiene measures—will continue to be implemented to control any potential spread. Additionally, MOH, in collaboration with the Ministry of Manpower and the National Environment Agency, has begun wastewater testing at migrant worker dormitories and the Onboard Centre to detect any presence of mpox.
Ongoing Surveillance and Preparedness
MOH will continue to work closely with international counterparts to monitor the evolving mpox situation. Border measures, detection protocols, and vaccination strategies will be adjusted as needed to safeguard Singapore’s public health.
As of now, Singapore has not detected any clade 1 cases, with all 14 mpox cases this year involving the less severe clade 2 subtype. However, Minister Ong stressed the importance of vigilance, particularly in protecting vulnerable groups such as children and the immunocompromised, should clade 1 reach Singapore.
“Our best course of action is to suppress the spread, provide proper treatment, and have an effective vaccination strategy in place,” Ong said. Despite the concern surrounding mpox, Ong reassured the public that it is unlikely to cause the level of disruption seen during COVID-19.
Health
Baby born with 26 fingers and toes in India, considered reincarnation of Hindu deity
A baby in Bharatpur, India, was born with 26 fingers and toes, believed to be a reincarnation of a Hindu deity.
A baby was born with an astonishing 26 fingers and toes in a hospital in Bharatpur, a city in the northern Indian state of Rajasthan.
While medical experts describe the condition as a genetic anomaly known as polydactyly, the baby’s family is rejoicing, believing that their child is the reincarnation of a revered Hindu deity.
The baby, whose name has not been disclosed, entered the world with 14 fingers on its hands and 12 toes on its feet, leaving medical professionals both astounded and intrigued.
As reported by the Daily Mail on Tuesday (19 Sep), doctors described it as a genetic anomaly known as polydactyly, where someone is born with one or more extra fingers or toes. It can occur on one or both hands or feet.
However, the family is reported to be happy and openly refers to it as a reincarnation of Dholagarh Devi, a famous local deity whose temple is located near the girl’s birthplace. The deity’s statue depicts a young girl with multiple hands.
The baby’s mother, Sarju Devi, aged 25, expressed immense joy at the birth of her child. Sarju Devi’s brother, whose name was not disclosed, spoke to local media, proudly stating, “My sister has given birth to a baby with 26 fingers, and we consider it to be the incarnation of Dholagarh Devi. We are overjoyed.”
The baby’s father, Gopal Bhattacharya, a Central Reserve Police Force officer, is also reported to be ecstatic about the birth.
Dr BS Soni, a medical practitioner at the hospital where the baby was born, offered a medical perspective on the condition, saying, “Having 26 fingers is not harmful, but it is a genetic abnormality. The little girl is perfectly healthy.”
The big question now is whether the family from Bharatpur, in the northern Indian state of Rajasthan, plans to undergo surgery to reduce the number of fingers and toes on their newborn baby.
This decision is yet to be disclosed as the family continues to bask in the belief that their child is a divine reincarnation.
-
Singapore5 days ago
Singapore woman’s suicide amidst legal battle raises concerns over legal system
-
Singapore1 day ago
Minister K Shanmugam transfers Astrid Hill GCB to UBS Trustees for S$88 Million following Ridout Road controversy
-
Diplomacy1 week ago
India PM Narendra Modi meets with PM Lawrence Wong; Four MoUs signed
-
Parliament3 days ago
Minister Shanmugam rejects request for detailed information on visa-free visitor offences: Cites bilateral considerations
-
Opinion1 week ago
Singaporean voters and the ‘Battered Wife Syndrome’
-
Parliament4 days ago
PAP MPs attack WP Gerald Giam in Parliament over NTUC independence from ruling party
-
Politics1 week ago
PAP adopts SDP policies after criticizing them: Dr Chee urges Singaporeans to see through tactics
-
Food1 week ago
NTU stall food prices questioned after parent pays S$6.30 for meal